Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Jan 2026 and Jul 2026.
- Largest single sale: $4.9M (148,517 shares) of Viking Therapeutics, Inc. on Jul 29, 2026. Filing
- Last sale before this period: Jul 3, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | President & CEO, Director | Apr 28, 2015 | Jul 29, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 29, 2026, Viking Therapeutics, Inc.: sold 148,517 shares for $4.9M, to cover taxes. 1 filing: 1
- Jul 28, 2026, Viking Therapeutics, Inc.: 221,667 shares awarded. 1 filing: 1
- Jan 5, 2026, Viking Therapeutics, Inc.: sold 233,409 shares for $7.7M, to cover taxes. 1 filing: 1
- Jan 2, 2026, Viking Therapeutics, Inc.: 302,480 shares awarded. 1 filing: 1
- Oct 28, 2025, Viking Therapeutics, Inc.: sold 38,989 shares for $1.4M, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.